ANEST IWATA Corporation (TYO:6381)
Japan · Delayed Price · Currency is JPY 1,704.00
-54.00 (-3.07%)
Feb 13, 2026, 3:30 PM JST
ANEST IWATA Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 53,911 | 54,411 | 53,425 | 48,515 | 42,337 | 35,588 | |
Revenue Growth (YoY) | -0.98% | 1.85% | 10.12% | 14.59% | 18.96% | -8.96% |
Cost of Revenue | 28,877 | 29,091 | 28,950 | 27,178 | 24,109 | 20,663 |
Gross Profit | 25,034 | 25,320 | 24,475 | 21,337 | 18,228 | 14,925 |
Selling, General & Admin | 10,598 | 19,023 | 17,869 | 15,184 | 13,242 | 11,285 |
Other Operating Expenses | 9,206 | 235 | 330 | 175 | 201 | 214 |
Operating Expenses | 19,963 | 19,417 | 18,299 | 15,498 | 13,447 | 11,481 |
Operating Income | 5,071 | 5,903 | 6,176 | 5,839 | 4,781 | 3,444 |
Interest Expense | -84 | -106 | -72 | -58 | -58 | -63 |
Interest & Investment Income | 288 | 298 | 246 | 139 | 126 | 122 |
Earnings From Equity Investments | 986 | 936 | 768 | 523 | 359 | 315 |
Currency Exchange Gain (Loss) | 266 | 21 | 739 | 464 | 231 | 87 |
Other Non Operating Income (Expenses) | 80 | 85 | 128 | 134 | 131 | 347 |
EBT Excluding Unusual Items | 6,607 | 7,137 | 7,985 | 7,041 | 5,570 | 4,252 |
Gain (Loss) on Sale of Investments | 215 | 143 | 14 | 56 | -23 | 10 |
Gain (Loss) on Sale of Assets | -88 | 21 | 10 | 8 | 3 | 9 |
Asset Writedown | -6 | -6 | -23 | -16 | -10 | -112 |
Other Unusual Items | - | -26 | - | - | - | -24 |
Pretax Income | 6,728 | 7,269 | 7,986 | 7,089 | 5,540 | 4,135 |
Income Tax Expense | 1,714 | 1,904 | 2,052 | 1,821 | 1,392 | 1,092 |
Earnings From Continuing Operations | 5,014 | 5,365 | 5,934 | 5,268 | 4,148 | 3,043 |
Minority Interest in Earnings | -938 | -1,089 | -1,003 | -887 | -607 | -420 |
Net Income | 4,076 | 4,276 | 4,931 | 4,381 | 3,541 | 2,623 |
Net Income to Common | 4,076 | 4,276 | 4,931 | 4,381 | 3,541 | 2,623 |
Net Income Growth | -16.34% | -13.28% | 12.55% | 23.72% | 35.00% | -3.46% |
Shares Outstanding (Basic) | 39 | 40 | 40 | 40 | 41 | 41 |
Shares Outstanding (Diluted) | 39 | 40 | 40 | 40 | 41 | 41 |
Shares Change (YoY) | -0.84% | -2.11% | -0.26% | -1.34% | -0.94% | -0.73% |
EPS (Basic) | 103.54 | 108.19 | 122.13 | 108.23 | 86.31 | 63.33 |
EPS (Diluted) | 103.54 | 108.19 | 122.13 | 108.23 | 86.31 | 63.33 |
EPS Growth | -15.63% | -11.42% | 12.84% | 25.40% | 36.28% | -2.76% |
Free Cash Flow | - | 7,083 | 4,952 | 2,482 | 3,023 | 4,090 |
Free Cash Flow Per Share | - | 179.21 | 122.65 | 61.32 | 73.68 | 98.75 |
Dividend Per Share | 64.000 | 45.000 | 49.000 | 38.000 | 30.000 | 24.000 |
Dividend Growth | 30.61% | -8.16% | 28.95% | 26.67% | 25.00% | - |
Gross Margin | 46.44% | 46.53% | 45.81% | 43.98% | 43.05% | 41.94% |
Operating Margin | 9.41% | 10.85% | 11.56% | 12.04% | 11.29% | 9.68% |
Profit Margin | 7.56% | 7.86% | 9.23% | 9.03% | 8.36% | 7.37% |
Free Cash Flow Margin | - | 13.02% | 9.27% | 5.12% | 7.14% | 11.49% |
EBITDA | 7,732 | 8,388 | 8,427 | 7,914 | 6,545 | 5,075 |
EBITDA Margin | 14.34% | 15.42% | 15.77% | 16.31% | 15.46% | 14.26% |
D&A For EBITDA | 2,661 | 2,485 | 2,251 | 2,075 | 1,764 | 1,631 |
EBIT | 5,071 | 5,903 | 6,176 | 5,839 | 4,781 | 3,444 |
EBIT Margin | 9.41% | 10.85% | 11.56% | 12.04% | 11.29% | 9.68% |
Effective Tax Rate | 25.48% | 26.19% | 25.70% | 25.69% | 25.13% | 26.41% |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.